Sponsor Pipeline

Hangzhou DAC Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07559929 A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung… Small Cell Lung Cancer Not Yet Recruiting
Phase 1
NCT06224855 A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies Advanced Solid Tumors Recruiting
NCT07177937 A Study of DXC014 in Patients With Advanced Solid Tumors. Small Cell Lung Cancer Recruiting
NCT06926283 A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors Prostate Cancer Recruiting
NCT07657806 DEC003M in Prostate Cancer Advanced Prostate Cancer Not Yet Recruiting
Disease Areas
Get alerts when Hangzhou DAC Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free